IL24 and Alzheimer disease: Therefore, our results in this study suggest that JAK inhibitors may strengthen the therapeutic effect of NB-UVB against skin barrier dysfunction in AD by blocking the JAK/STAT3 axis activated by FICZ/AHR-induced IL-24.